[{"orgOrder":0,"company":"Admescope","sponsor":"Admescope","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"FINLAND","productType":"Controlled Substance","year":"2015","type":"Inapplicable","leadProduct":"Fentanyl","moa":"Mu opioid receptor","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Phase IV","graph3":"Admescope","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Admescope \/ Admescope","highestDevelopmentStatusID":"11","companyTruncated":"Admescope \/ Admescope"},{"orgOrder":0,"company":"Admescope","sponsor":"Admescope","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"FINLAND","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Oxycodone Hydrochloride","moa":"Mu opioid receptor","graph1":"Gastroenterology","graph2":"Phase IV","graph3":"Admescope","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Tablet, Prolonged Release","sponsorNew":"Admescope \/ Admescope","highestDevelopmentStatusID":"11","companyTruncated":"Admescope \/ Admescope"},{"orgOrder":0,"company":"Admescope","sponsor":"Admescope","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"FINLAND","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Oxycodone Hydrochloride","moa":"Mu opioid receptor","graph1":"Neurology","graph2":"Phase IV","graph3":"Admescope","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Admescope \/ Admescope","highestDevelopmentStatusID":"11","companyTruncated":"Admescope \/ Admescope"},{"orgOrder":0,"company":"Admescope","sponsor":"Admescope","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"FINLAND","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Oxycodone Hydrochloride","moa":"Mu opioid receptor","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Phase IV","graph3":"Admescope","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Admescope \/ Admescope","highestDevelopmentStatusID":"11","companyTruncated":"Admescope \/ Admescope"},{"orgOrder":0,"company":"Admescope","sponsor":"Admescope","pharmaFlowCategory":"DU","therapeuticArea":"Trauma (Emergency, Injury, Surgery)","country":"FINLAND","productType":"Miscellaneous","year":"2016","type":"Inapplicable","leadProduct":"Levobupivacaine","moa":"Sodium channel protein type IV alpha subunit","graph1":"Trauma (Emergency, Injury, Surgery)","graph2":"Phase IV","graph3":"Admescope","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Trauma","amount2New":0,"dosageForm":"Catheter","sponsorNew":"Admescope \/ Admescope","highestDevelopmentStatusID":"11","companyTruncated":"Admescope \/ Admescope"}]